P H Wiernik
About
In The Last Decade
P H Wiernik
69 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 100
- Oncology 847
- Hematology 441
- Molecular Biology 369
- Pathology and Forensic Medicine 328
- Pulmonary and Respiratory Medicine 318
Countries citing papers authored by P H Wiernik
This map shows the geographic impact of P H Wiernik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P H Wiernik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P H Wiernik more than expected).
Fields of papers citing papers by P H Wiernik
This network shows the impact of papers produced by P H Wiernik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P H Wiernik. The network helps show where P H Wiernik may publish in the future.
Co-authorship network of co-authors of P H Wiernik
This figure shows the co-authorship network connecting the top 25 collaborators of P H Wiernik. A scholar is included among the top collaborators of P H Wiernik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P H Wiernik. P H Wiernik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Allogeneic transplant (related or unrelated donor) is the preferred treatment for adult Philadelphia chromosome positive (Ph+) acute lymphoblastic leukaemia (ALL). Results from the international ALL trial (MRC UKALLXII/ECOG E2993) | 21 |
| 2 | Favorable results of allogeneic bone marrow transplantation (BMT) for adults with Philadelphia (Ph)-chromosome-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR): Results from the International ALL trial (MRC UKALL XII/ECOG E2993). | 21 |
| 3 | 5 | |
| 4 | 26 | |
| 5 | Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient. | 125 |
| 6 | Philadelphia chromosome plus ve patients with adult acute lymphoblastic leukaemia (ALL), early results from the international ALL trial (MRC UKALL-XII/ECOG E2993). | 1 |
| 7 | 42 | |
| 8 | 16 | |
| 9 | 20 | |
| 10 | 114 | |
| 11 | 6 | |
| 12 | 12 | |
| 13 | 67 | |
| 14 | 2 | |
| 15 | 271 | |
| 16 | Reversible central nervous system toxicity associated with high-dose chlorambucil in autologous bone marrow transplantation for ovarian carcinoma. | 4 |
| 17 | 11 | |
| 18 | High performance liquid chromatographic analysis (HPLC) and human pharmacokinetics of taxol (NSC 125973) | 2 |
| 19 | Adriamycin in management of malignant hemangiopericytoma. | 10 |
| 20 | Ophthalmologic toxicity after cis-dichlorodiammineplatinum(II) therapy. | 53 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.